CLINDAMYCIN Safety Questions, CLINDAMYCIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CLINDAMYCIN. Our extensive database of CLINDAMYCIN adverse events and CLINDAMYCIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CLINDAMYCIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




CLINDAMYCIN Safety Reports

Total CLINDAMYCIN reports: 166.
CLINDAMYCIN FDA safety alerts: No.
Reported deaths: 8    Reported hospitalizations: 60.
Take CLINDAMYCIN Side Effects Survey or Share Your CLINDAMYCIN Story. CLINDAMYCIN Usage.

Showing 1-75 of 166 Next >

Health Professional from GREECE reported CLINDAMYCIN problem on July 31, 2006. Male patient, 57 years of age, was diagnosed with tooth abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic. CLINDAMYCIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Female patient, 70 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, candidiasis, diarrhoea, musculoskeletal pain, pain in extremity, urticaria. CLINDAMYCIN dosage: 150 MG. Patient recovered.

Physician from JAPAN reported CLINDAMYCIN problem on Aug 03, 2006. Female patient, child 10 years of age, weighting 55.12 lb, was diagnosed with mastoiditis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: pruritus, pyrexia, toxic skin eruption, viral rash. CLINDAMYCIN dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with CARBENIN. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Pharmacist from UNITED STATES on Aug 17, 2006. Male patient, weighting 190.0 lb, was diagnosed with cellulitis, osteomyelitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: erythema, rash. CLINDAMYCIN dosage: 900 MG Q8H IV. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Aug 18, 2006. Male patient, 62 years of age, weighting 235.0 lb, was diagnosed with tooth impacted and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: anorexia, blister, dizziness, sensation of heaviness, vision blurred. CLINDAMYCIN dosage: unknown. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from FRANCE on Aug 08, 2006. Female patient, 47 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dermatitis allergic, pyrexia, skin test positive. CLINDAMYCIN dosage: 1200 MG (600 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with GENTAMICIN, TAGAMET, METRONIDAZOLE, ACETAMINOPHEN, ACUPAN, CELOCURIN, NIMBEX, RINGER. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Aug 23, 2006. Male patient, weighting 79.81 lb, was diagnosed with osteoarthritis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea. CLINDAMYCIN dosage: 350MG EVERY 8 HOURS IV BOLUS. During the same period patient was treated with IBUPROFEN, ACETAMINOPHEN. Patient recovered.

CLINDAMYCIN problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2006. Male patient, 48 years of age, weighting 311.0 lb, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, dyspnoea, electromechanical dissociation, hot flush, loss of consciousness, procedural complication, ventricular fibrillation. CLINDAMYCIN dosage: 600 MG ONE TIME IV [ ONE TIME DOSE]. Patient died on 10/05/2005.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Aug 09, 2006. Male patient, 81 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: anal discomfort, dizziness, dysgeusia, rectal discharge. CLINDAMYCIN dosage: 150 MG. During the same period patient was treated with ALAPURINOL, ALTASE, NORVASC, LIPITOR, METAPROLOL. Patient recovered.

CLINDAMYCIN problem was reported by a Pharmacist from SPAIN on Aug 09, 2006. Male patient, 39 years of age, was diagnosed with hiv infection, pain, cellulitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: hepatitis c virus, hepatitis cholestatic. CLINDAMYCIN dosage: (150 MG, FREQUENCY: TID INTERVAL: WEEK), ORAL. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE, TENOFOVIR, IBUPROFEN, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported CLINDAMYCIN problem on Aug 09, 2006. Female patient was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: administration site reaction, incorrect dose administered, paraesthesia. CLINDAMYCIN dosage: unknown. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from GERMANY on Aug 16, 2006. Female patient, 50 years of age, was diagnosed with tooth disorder, trigeminal neuralgia and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: iatrogenic injury, impaired work ability, pancreatitis, pseudomembranous colitis, trigeminal neuralgia. CLINDAMYCIN dosage: unknown. During the same period patient was treated with VALORON N RETARD, OMEPRAZOLE, ANAFRANIL. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Aug 30, 2006. Female patient was diagnosed with cellulitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: pruritus. CLINDAMYCIN dosage: 900 MG Q 6 HOURS IV. Patient recovered.

CLINDAMYCIN problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2006. Male patient, 48 years of age, weighting 253.0 lb, was diagnosed with arthritis bacterial and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: face oedema, rash erythematous, rash pruritic. CLINDAMYCIN dosage: 450MG TID PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Sept 08, 2006. Female patient, 30 years of age, weighting 125.0 lb, was diagnosed with dental disorder prophylaxis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: nausea, pruritus, urticaria. CLINDAMYCIN dosage: FOUR -4- 150MG CAPSULES ONE TIME PO. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from UNITED STATES on Aug 31, 2006. Female patient, 21 years of age, was diagnosed with pharyngitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: blood urine present, gait disturbance, henoch-schonlein purpura, oedema peripheral. CLINDAMYCIN dosage: unknown. Patient recovered.

Physician from SWITZERLAND reported CLINDAMYCIN problem on Sept 04, 2006. Female patient was diagnosed with acne, depression, asthma and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. CLINDAMYCIN dosage: unknown. During the same period patient was treated with DIFFERIN, SEROPRAM, VENTOLIN, PROCUTOL. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2006. Male patient, 42 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: convulsion, depressed level of consciousness, dysarthria, dyskinesia, haemodialysis. CLINDAMYCIN dosage: unknown. During the same period patient was treated with CEFAZOLIN, RIFADIN, BLOPRESS, RABEPRAZOLE, AMLODIPINE. Patient was hospitalized. Patient recovered.

Physician from INDIA reported CLINDAMYCIN problem on Sept 07, 2006. Female patient was diagnosed with wound infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: aggression, irritability. CLINDAMYCIN dosage: 1800 MG (600 MG, 3 IN 1 D), INTRAVENOUS. During the same period patient was treated with DIAZEPAM, HALOPERIDOL, AUGMENTIN, METROGYL. Patient died.

CLINDAMYCIN problem was reported by a Physician from PHILIPPINES on Sept 08, 2006. Female patient was diagnosed with tonsillitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, rash. CLINDAMYCIN dosage: 300 MG (300 MG, INTERVAL: ONE DOSE ONLY), ORAL. During the same period patient was treated with CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Physician from PHILIPPINES reported CLINDAMYCIN problem on Sept 11, 2006. Male patient, 75 years of age, was diagnosed with abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. CLINDAMYCIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with CLOXACILLIN BENZATHINE, AULIN. Patient recovered.

CLINDAMYCIN problem was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Male patient, child 5 years of age, weighting 48.50 lb, was diagnosed with osteomyelitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: rash. CLINDAMYCIN dosage: 220 MG Q8H IV. Patient recovered.

Health Professional from UNITED STATES reported CLINDAMYCIN problem on Sept 27, 2006. Female patient, 18 years of age, weighting 120.6 lb, was diagnosed with wound infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, erythema, oedema peripheral, pruritus. CLINDAMYCIN dosage: 500 MG Q8H IV. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Male patient, 54 years of age, weighting 180.0 lb, was diagnosed with tooth abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, abnormal faeces, alcohol use, diarrhoea, gastrointestinal disorder, haematochezia, neoplasm. CLINDAMYCIN dosage: 300 MG 6 HOURS PO. During the same period patient was treated with ETODOLAC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Oct 02, 2006. Male patient, 44 years of age, weighting 133.0 lb, was diagnosed with abscess, infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, asthenia, blood pressure decreased, chills, cold sweat, dysgeusia, fatigue, feeling abnormal, heart rate increased. CLINDAMYCIN dosage: 900MG 1 IV DRIP. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Male patient, 81 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: anal discomfort, dizziness, dysgeusia, rectal discharge. CLINDAMYCIN dosage: 150 MG. During the same period patient was treated with ALAPURINOL, ALTASE, NORVASC, LIPITOR, METAPROLOL. Patient recovered.

Health Professional from UNITED STATES reported CLINDAMYCIN problem on Oct 05, 2006. Female patient, 46 years of age, weighting 151.0 lb, was diagnosed with breast cancer and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: infusion related reaction. CLINDAMYCIN dosage: 600 MG IV TID [2ND DOSE 2200]. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2006. Male patient, 42 years of age, weighting 90.39 lb, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, depressed level of consciousness, diabetic nephropathy, dysarthria, dyskinesia, haemodialysis, muscular weakness, myoclonus. CLINDAMYCIN dosage: unknown. During the same period patient was treated with CEFAZOLIN, RIFADIN, BLOPRESS, RABEPRAZOLE, AMLODIPINE, UNASYN, ESPO. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Oct 13, 2006. Female patient, 59 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: rash erythematous, rash pruritic. CLINDAMYCIN dosage: ORAL 150.0 MILLIGRAM. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 38 years of age, was diagnosed with injection site infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: skin exfoliation. CLINDAMYCIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from CANADA reported CLINDAMYCIN problem on Oct 06, 2006. Female patient, 24 years of age, was diagnosed with vaginitis bacterial and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 43 years of age, weighting 157.0 lb, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper. CLINDAMYCIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Oct 24, 2006. Male patient, 58 years of age, weighting 167.8 lb, was diagnosed with localised infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: swollen tongue. CLINDAMYCIN dosage: unknown. During the same period patient was treated with VANCOMYCIN, LINEZOLID, HYDROCODONE BITARTRATE, ENSURE PLUS, OCTREOTIDE ACETATE, CITALOPRAM HYDROBROMIDE, CALCITONIN. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from NETHERLANDS on Oct 10, 2006. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with bacterial infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. CLINDAMYCIN dosage: 1800 MG (600 MG, 3 IN 1 D). During the same period patient was treated with BENZYLPENICILLIN, CIPROFLOXACIN, ENALAPRIL MALEATE, CALCICHEW, POLYSTYRENE SULFONATE, TAVEGYL, FRAXIPARINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Oct 17, 2006. Male patient, child 12 years of age, was diagnosed with staphylococcal infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: hallucination, migraine, tinnitus. CLINDAMYCIN dosage: 450 MG (150 MG, 3 IN 1 D). Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from FRANCE on Oct 12, 2006. Female patient, 50 years of age, was diagnosed with tooth extraction and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, ill-defined disorder, leukocytosis, syncope, vomiting. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Oct 27, 2006. Female patient, 50 years of age, weighting 156.0 lb, was diagnosed with endodontic procedure, infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: stomatitis. CLINDAMYCIN dosage: unknown. Patient recovered.

CLINDAMYCIN problem was reported by a Pharmacist from JAPAN on Oct 17, 2006. Female patient, 63 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. CLINDAMYCIN dosage: 1200 MG (600 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PIPERACILLIN, TRANSAMIN, LOXONIN, FERROMIA. Patient recovered.

Physician from INDIA reported CLINDAMYCIN problem on Oct 19, 2006. Female patient, 35 years of age, was diagnosed with wound infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: aggression, cardio-respiratory arrest, completed suicide, irritability, laceration. CLINDAMYCIN dosage: 1200 MG (600 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with DIAZEPAM, HALOPERIDOL, AUGMENTIN, METROGYL, OMNATAX, GENTAMICIN SULPHATE, RANTAC, PHENYTOIN. Patient died on 08/19/2006.

CLINDAMYCIN problem was reported by a Physician from DENMARK on Oct 20, 2006. Male patient, 16 years of age, was diagnosed with acne and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: caustic injury, corneal scar, iritis. CLINDAMYCIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Nov 13, 2006. Male patient, weighting 107.0 lb, was diagnosed with staphylococcal osteomyelitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: rash, urticaria. CLINDAMYCIN dosage: 500MG Q8H IV. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2006. Female patient, 49 years of age, weighting 189.0 lb, was diagnosed with oral infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: depression. CLINDAMYCIN dosage: unknown. Patient recovered.

Consumer or non-health professional from FINLAND reported CLINDAMYCIN problem on Nov 01, 2006. Female patient was diagnosed with infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, clostridial infection, diarrhoea, haemorrhoidal haemorrhage, rectal haemorrhage. CLINDAMYCIN dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from FINLAND on Nov 02, 2006. Male patient, 15 years of age, weighting 286.6 lb, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: alcohol intolerance. CLINDAMYCIN dosage: 2400 MG (600 MG, 4 IN 1 D), INTRAVENOUS. During the same period patient was treated with METRONIDAZOLE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Nov 21, 2006. Female patient, 39 years of age, weighting 155.0 lb, was diagnosed with tooth infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: colitis, haemorrhage. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Health Professional from UNITED KINGDOM on Nov 06, 2006. Female patient, 55 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: nausea, vertigo, vomiting. CLINDAMYCIN dosage: unknown. During the same period patient was treated with ERYTHROMYCIN, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported CLINDAMYCIN problem on Nov 07, 2006. Male patient, 49 years of age, was diagnosed with inflammation and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: foreign body trauma, nausea, odynophagia, oesophageal oedema, vomiting. CLINDAMYCIN dosage: 1200 MG (300 MG, 4 IN 1 ), ORAL. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Male patient, 75 years of age, weighting 135.0 lb, was diagnosed with gingival infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, depression, gastritis, nausea, oral intake reduced, rash, weight decreased. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Nov 27, 2006. Female patient, 93 years of age, weighting 155.0 lb, was diagnosed with localised infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood potassium decreased, colitis, renal failure, white blood cell count increased. CLINDAMYCIN dosage: 300 MG 4X DAY FOR 10 DAYS PO. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from GERMANY on Nov 13, 2006. Male patient, 50 years of age, was diagnosed with tooth disorder and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: epiglottic oedema, foreign body trauma, pharyngeal oedema, pharyngolaryngeal pain. CLINDAMYCIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on Nov 30, 2006. Male patient, weighting 228.0 lb, was diagnosed with postoperative care, uvulopalatopharyngoplasty and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: rash, urticaria. CLINDAMYCIN dosage: 4 TSP -20ML- QID PO. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, 79 years of age, weighting 251.1 lb, was diagnosed with prophylaxis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: nausea, rash, urticaria, vomiting. CLINDAMYCIN dosage: 600MG, 600 MG P, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Dec 12, 2006. Female patient, weighting 125.0 lb, was diagnosed with urinary tract infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain, heart rate increased. CLINDAMYCIN dosage: 300 MG 3X/DAY ORAL. Patient recovered.

CLINDAMYCIN problem was reported by a Health Professional from FRANCE on Nov 28, 2006. Female patient, 93 years of age, was diagnosed with erysipelas and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption, urinary tract infection. CLINDAMYCIN dosage: 2400 MG (600 MG, 4 IN 1 D), INTRAVENOUS. During the same period patient was treated with AMOXICILLIN, PENICILLIN G PROCAINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported CLINDAMYCIN problem on Nov 27, 2006. Female patient, 59 years of age, was diagnosed with respiratory tract infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, dysstasia, shock. CLINDAMYCIN dosage: unknown. During the same period patient was treated with SOLITA. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from GERMANY on Nov 28, 2006. Female patient, 33 years of age, was diagnosed with tooth disorder and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dysphonia, oedema peripheral, swollen tongue. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from PAKISTAN reported CLINDAMYCIN problem on Dec 06, 2006. Male patient, 40 years of age, was diagnosed with postoperative wound infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin discolouration. CLINDAMYCIN dosage: 600 MG (600 MG, 1 IN 1 D), INTRAVENOUS. Patient recovered.

CLINDAMYCIN problem was reported by a Health Professional from FRANCE on Dec 06, 2006. Male patient, 69 years of age, was diagnosed with abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, face oedema, rash pustular, skin test positive, toxic skin eruption. CLINDAMYCIN dosage: unknown. During the same period patient was treated with FUSIDIC ACID, FOSFOMYCIN, DOMPERIDONE, MORPHINE SULPHATE, VANCOMYCIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported CLINDAMYCIN problem on Dec 07, 2006. Male patient, 74 years of age, weighting 114.6 lb, was diagnosed with pneumonia and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: cholangitis acute, cholestasis, condition aggravated, liver disorder, pneumonia. CLINDAMYCIN dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with UNASYN, MEROPEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2006. Male patient, 13 years of age, weighting 100.0 lb, was diagnosed with staphylococcal infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: clostridial infection. CLINDAMYCIN dosage: unknown. Patient recovered.

Health Professional from GERMANY reported CLINDAMYCIN problem on Oct 16, 2006. Female patient, weighting 132.3 lb, was diagnosed with tooth abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: gastritis, gastrointestinal ulcer, oesophagitis. CLINDAMYCIN dosage: unknown. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2006. Female patient, 16 years of age, weighting 100.0 lb, was diagnosed with staphylococcal infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: clostridial infection. CLINDAMYCIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Dec 27, 2006. Female patient, 80 years of age, weighting 144.0 lb, was diagnosed with dental operation, prophylaxis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, malaise. CLINDAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from JAPAN on Dec 08, 2006. Female patient, 74 years of age, weighting 104.7 lb, was diagnosed with pyrexia and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, liver disorder, skin test positive. CLINDAMYCIN dosage: 1200 MG (600 MG, 2 IN 1D); INTRAVENOUS. During the same period patient was treated with ADETPHOS, MERISLON, TRAVELMIN, NIVADIL, NORFLOXACIN, EMPYNASE, VOLTAREN. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported CLINDAMYCIN problem on Dec 11, 2006. Female patient, 36 years of age, was treated with CLINDAMYCIN. CLINDAMYCIN dosage: unknown. During the same period patient was treated with RAMIPRIL, OFLOXACIN, INSULIN, XALATAN, COSOPT. Patient died.

CLINDAMYCIN problem was reported by a Physician from INDIA on June 28, 2007. Male patient, 55 years of age, was diagnosed with necrotising fasciitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, chills. CLINDAMYCIN dosage: unknown. During the same period patient was treated with CEFIZOX. Patient died on 06/13/2007.

Physician from GREECE reported CLINDAMYCIN problem on June 29, 2007. Female patient, 67 years of age, weighting 127.9 lb, was diagnosed with chronic sinusitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: pruritus, pyrexia, rash morbilliform. CLINDAMYCIN dosage: unknown. During the same period patient was treated with RONAL, LOSEC. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from BRAZIL on July 05, 2007. Female patient, weighting 165.3 lb, was diagnosed with infection and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, arterial disorder, arteriosclerosis, finger amputation, hypertension, leg amputation, nausea, vomiting. CLINDAMYCIN dosage: unknown. During the same period patient was treated with CORENITEC, OMEPRAZOLE, FLUOXETINE, CEPHALEXIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CLINDAMYCIN problem on July 17, 2007. Male patient, 47 years of age, weighting 278.0 lb, was diagnosed with cellulitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: rash maculo-papular. CLINDAMYCIN dosage: 300 MG TID PO. Patient recovered.

CLINDAMYCIN problem was reported by a Consumer or non-health professional from GERMANY on July 10, 2007. Male patient, 32 years of age, was diagnosed with furuncle, depression and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dyskinesia. CLINDAMYCIN dosage: DAILY DOSE:300MG. During the same period patient was treated with FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE. Patient recovered.

Health Professional from GERMANY reported CLINDAMYCIN problem on July 02, 2007. Male patient, 32 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: anhedonia, asthenia, cluster headache, cyclothymic disorder, depression, disease recurrence, disturbance in attention, dyskinesia. CLINDAMYCIN dosage: 300 MG, QD,. During the same period patient was treated with FLUVOXAMINE MALEATE. Patient recovered.

CLINDAMYCIN problem was reported by a Physician from GREECE on July 12, 2007. Female patient, 67 years of age, weighting 127.9 lb, was diagnosed with chronic sinusitis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: pruritus, pyrexia, rash morbilliform. CLINDAMYCIN dosage: unknown. During the same period patient was treated with RONAL, LOSEC. Patient recovered.

Pharmacist from UNITED STATES reported CLINDAMYCIN problem on July 26, 2007. Male patient, 91 years of age, weighting 185.0 lb, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, oesophagitis. CLINDAMYCIN dosage: 600 MG PO Q8H. During the same period patient was treated with PREDNISONE, ALBUTEROL, IMDUR, LUMIGAN, SPIRIVA, FUROSEMIDE, DOCUSATE. Patient recovered.

CLINDAMYCIN problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Male patient, 32 years of age, was diagnosed with furuncle and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: dyskinesia, furuncle. CLINDAMYCIN dosage: 300 MG/DAILY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Aug 07, 2007. Male patient, 42 years of age, weighting 195.0 lb, was diagnosed with gingival abscess and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, muscle spasms. CLINDAMYCIN dosage: 1 300MG CAPSUL 3 TIMES DAILY PO. Patient recovered.

Showing 1-75 of 166 Next >

Ask Our Patient Community about CLINDAMYCIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoeti